First Page | Document Content | |
---|---|---|
Date: 2016-08-04 23:27:20Breakthrough therapy Chemistry Pharmaceutical sciences Carbamates Pharmacology Pyrrolidines Ombitasvir/paritaprevir/ritonavir Ritonavir Ombitasvir AbbVie Inc. Paritaprevir Kidney | Pharmaceuticals and Medical Devices Agency This English version is intended to be a reference material for the convenience of users. In the event of inconsistency between the Japanese original and this English translatioAdd to Reading ListSource URL: www.pmda.go.jpDownload Document from Source WebsiteFile Size: 95,95 KBShare Document on Facebook |
Chemistry_BS_Biochemistry.pdfDocID: 1xUCR - View Document | |
Chemistry_BS_Environmental Chemistry.pdfDocID: 1xUxX - View Document | |
Chemistry, BA "DBEFNJD.BQ GeneralDocID: 1xU5A - View Document | |
The Next Bigly Thing -- Torsion Chemistry 80% Faster Reactions, 50% Less Energy with "Activators" by Robert A. Nelson Science has bestowed many wonderments upon us, but the Return-On-Investment is quickly diminishing (thDocID: 1xTUH - View Document | |
Chemistry_BS_General BS to MS Accelerated Pathway.pdfDocID: 1xTpY - View Document |